End-of-day quote
Thailand S.E.
06:00:00 2024-04-25 pm EDT
|
5-day change
|
1st Jan Change
|
2.86
THB
|
-1.38%
|
|
+2.88%
|
-8.92%
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Capitalization
1 |
28,380
|
27,060
|
40,260
|
40,480
|
34,540
|
31,460
|
-
|
-
|
Enterprise Value (EV)
1 |
29,398
|
27,626
|
37,915
|
39,278
|
34,540
|
30,073
|
29,504
|
28,644
|
P/E ratio
|
40.3
x
|
30.8
x
|
9.63
x
|
14.5
x
|
33.1
x
|
25.3
x
|
22.6
x
|
22
x
|
Yield
|
1.94%
|
2.03%
|
5.46%
|
4.35%
|
-
|
2.76%
|
3.08%
|
3.32%
|
Capitalization / Revenue
|
5.49
x
|
4.98
x
|
3.43
x
|
4.01
x
|
4.47
x
|
3.66
x
|
3.36
x
|
3.09
x
|
EV / Revenue
|
5.69
x
|
5.09
x
|
3.23
x
|
3.89
x
|
4.47
x
|
3.5
x
|
3.16
x
|
2.82
x
|
EV / EBITDA
|
24.6
x
|
18.6
x
|
7.04
x
|
10.8
x
|
22.5
x
|
14.9
x
|
13.1
x
|
12.2
x
|
EV / FCF
|
111
x
|
27.4
x
|
10.7
x
|
21.3
x
|
-
|
21.9
x
|
21.8
x
|
18.7
x
|
FCF Yield
|
0.9%
|
3.65%
|
9.34%
|
4.69%
|
-
|
4.57%
|
4.59%
|
5.35%
|
Price to Book
|
7.67
x
|
6.72
x
|
5.32
x
|
5.38
x
|
-
|
4.05
x
|
3.74
x
|
3.54
x
|
Nbr of stocks (in thousands)
|
11,000,000
|
11,000,000
|
11,000,000
|
11,000,000
|
11,000,000
|
11,000,000
|
-
|
-
|
Reference price
2 |
2.580
|
2.460
|
3.660
|
3.680
|
3.140
|
2.860
|
2.860
|
2.860
|
Announcement Date
|
2/28/20
|
2/25/21
|
2/25/22
|
2/23/23
|
2/23/24
|
-
|
-
|
-
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net sales
1 |
5,166
|
5,433
|
11,742
|
10,103
|
7,730
|
8,599
|
9,351
|
10,172
|
EBITDA
1 |
1,194
|
1,486
|
5,389
|
3,642
|
1,537
|
2,025
|
2,261
|
2,356
|
EBIT
1 |
863.9
|
1,133
|
5,038
|
3,260
|
1,097
|
1,316
|
1,559
|
1,719
|
Operating Margin
|
16.72%
|
20.85%
|
42.91%
|
32.27%
|
14.19%
|
15.3%
|
16.67%
|
16.9%
|
Earnings before Tax (EBT)
1 |
848.7
|
1,071
|
5,276
|
3,554
|
1,346
|
1,582
|
1,788
|
1,988
|
Net income
1 |
705.2
|
876.6
|
4,204
|
2,778
|
1,046
|
1,245
|
1,420
|
1,556
|
Net margin
|
13.65%
|
16.14%
|
35.8%
|
27.5%
|
13.53%
|
14.47%
|
15.18%
|
15.29%
|
EPS
2 |
0.0640
|
0.0800
|
0.3800
|
0.2530
|
0.0950
|
0.1130
|
0.1264
|
0.1300
|
Free Cash Flow
1 |
263.7
|
1,008
|
3,543
|
1,843
|
-
|
1,373
|
1,354
|
1,532
|
FCF margin
|
5.1%
|
18.56%
|
30.17%
|
18.25%
|
-
|
15.97%
|
14.48%
|
15.06%
|
FCF Conversion (EBITDA)
|
22.09%
|
67.85%
|
65.74%
|
50.61%
|
-
|
67.83%
|
59.88%
|
65.01%
|
FCF Conversion (Net income)
|
37.39%
|
115.04%
|
84.27%
|
66.34%
|
-
|
110.33%
|
95.36%
|
98.47%
|
Dividend per Share
2 |
0.0500
|
0.0500
|
0.2000
|
0.1600
|
-
|
0.0789
|
0.0881
|
0.0950
|
Announcement Date
|
2/28/20
|
2/25/21
|
2/25/22
|
2/23/23
|
2/23/24
|
-
|
-
|
-
|
Fiscal Period: December |
2020 S1
|
2020 S2
|
2021 S1
|
2021 Q3
|
2021 Q4
|
2022 Q1
|
2022 Q2
|
2022 S1
|
2022 Q3
|
2022 Q4
|
2023 Q1
|
2023 Q2
|
2023 Q3
|
2023 Q4
|
---|
Net sales
1 |
2,473
|
-
|
3,486
|
4,458
|
3,866
|
3,571
|
2,784
|
6,356
|
2,026
|
1,721
|
1,716
|
1,799
|
2,093
|
2,123
|
EBITDA
1 |
-
|
-
|
1,213
|
2,048
|
2,317
|
1,824
|
1,227
|
-
|
468
|
331.2
|
338.5
|
300.3
|
554.3
|
421.2
|
EBIT
1 |
-
|
-
|
-
|
1,961
|
2,226
|
1,665
|
1,064
|
-
|
367.2
|
237.8
|
239.6
|
196.2
|
437.6
|
300.4
|
Operating Margin
|
-
|
-
|
-
|
43.98%
|
57.57%
|
46.61%
|
38.23%
|
-
|
18.12%
|
13.82%
|
13.96%
|
10.91%
|
20.91%
|
14.15%
|
Earnings before Tax (EBT)
1 |
-
|
-
|
1,031
|
1,956
|
2,290
|
1,729
|
1,133
|
2,861
|
363.5
|
328.5
|
305.5
|
261.9
|
426.8
|
352.2
|
Net income
1 |
-
|
-
|
827.9
|
1,564
|
1,813
|
1,356
|
878.2
|
2,235
|
258.5
|
285.3
|
240.4
|
206
|
325.8
|
273.8
|
Net margin
|
-
|
-
|
23.75%
|
35.07%
|
46.89%
|
37.98%
|
31.54%
|
35.16%
|
12.76%
|
16.58%
|
14.01%
|
11.46%
|
15.57%
|
12.9%
|
EPS
2 |
-
|
-
|
0.0753
|
0.1421
|
0.1626
|
0.1233
|
0.0798
|
0.2031
|
0.0235
|
0.0264
|
0.0219
|
0.0187
|
0.0296
|
0.0200
|
Dividend per Share
|
0.0200
|
0.0300
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
0.0750
|
-
|
-
|
-
|
-
|
Announcement Date
|
8/14/20
|
2/25/21
|
8/11/21
|
11/12/21
|
2/25/22
|
5/13/22
|
8/15/22
|
8/15/22
|
11/11/22
|
2/23/23
|
5/11/23
|
8/10/23
|
11/14/23
|
2/23/24
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net Debt
1 |
1,018
|
566
|
-
|
-
|
-
|
-
|
-
|
-
|
Net Cash position
1 |
-
|
-
|
2,345
|
1,202
|
-
|
1,387
|
1,956
|
2,816
|
Leverage (Debt/EBITDA)
|
0.8527
x
|
0.3808
x
|
-
|
-
|
-
|
-
|
-
|
-
|
Free Cash Flow
1 |
264
|
1,008
|
3,543
|
1,843
|
-
|
1,373
|
1,354
|
1,532
|
ROE (net income / shareholders' equity)
|
19.4%
|
22.7%
|
72.5%
|
36.8%
|
-
|
16.2%
|
17.2%
|
18.2%
|
ROA (Net income/ Total Assets)
|
11.8%
|
14.1%
|
50.2%
|
26.7%
|
-
|
12.3%
|
13.4%
|
14.4%
|
Assets
1 |
5,987
|
6,233
|
8,375
|
10,415
|
-
|
10,160
|
10,568
|
10,777
|
Book Value Per Share
2 |
0.3400
|
0.3700
|
0.6900
|
0.6800
|
-
|
0.7100
|
0.7700
|
0.8100
|
Cash Flow per Share
2 |
0.0900
|
0.1200
|
0.3600
|
0.2400
|
-
|
0.1700
|
0.1900
|
0.2000
|
Capex
1 |
710
|
289
|
481
|
786
|
-
|
607
|
462
|
450
|
Capex / Sales
|
13.75%
|
5.32%
|
4.09%
|
7.78%
|
-
|
7.05%
|
4.94%
|
4.42%
|
Announcement Date
|
2/28/20
|
2/25/21
|
2/25/22
|
2/23/23
|
2/23/24
|
-
|
-
|
-
|
Last Close Price
2.86
THB Average target price
3.348
THB Spread / Average Target +17.06% Consensus |
1st Jan change
|
Capi.
|
---|
| -8.92% | 849M | | -14.92% | 84.68B | | +13.30% | 81.12B | | +10.92% | 29.4B | | -12.71% | 16.73B | | -3.06% | 16.36B | | -2.63% | 14.92B | | -31.75% | 11.77B | | -1.42% | 11.72B | | +27.44% | 11.71B |
Other Healthcare Facilities & Services
|